These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20009935)

  • 21. [Coronary stents and non-cardiac surgery: current management strategies].
    Carrasco P; López R; Lema G
    Rev Med Chil; 2011 Jun; 139(6):787-93. PubMed ID: 22051761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-eluting coronary artery stents.
    Dehmer GJ; Smith KJ
    Am Fam Physician; 2009 Dec; 80(11):1245-51. PubMed ID: 19961137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Coronary stents and anaesthesia: it is time to have national data].
    Vichova Z; Albaladejo P; Marret E; Lehot JJ; Monier F; Marcotte G; Samama CM; Piriou V
    Ann Fr Anesth Reanim; 2007 Feb; 26(2):157-60. PubMed ID: 17188455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stent thrombosis with drug-eluting stents: a re-examination of the evidence.
    Kedia G; Lee MS
    Catheter Cardiovasc Interv; 2007 May; 69(6):782-9. PubMed ID: 17394249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based management of patients undergoing PCI: stent controversies.
    Vetrovec GW
    Catheter Cardiovasc Interv; 2010 Mar; 75 Suppl 1():S39-42. PubMed ID: 20333706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
    Tan VP; Yan BP; Kiernan TJ; Ajani AE
    Cardiovasc Revasc Med; 2009; 10(1):36-44. PubMed ID: 19159853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stent thrombosis.
    Holmes DR; Kereiakes DJ; Garg S; Serruys PW; Dehmer GJ; Ellis SG; Williams DO; Kimura T; Moliterno DJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1357-65. PubMed ID: 20946992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The conundrum of late and very late stent thrombosis following drug-eluting stent implantation.
    Garg P; Mauri L
    Curr Opin Cardiol; 2007 Nov; 22(6):565-71. PubMed ID: 17921745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary stents and subsequent surgery: reported provider attitudes and practice patterns.
    Graham LA; Maddox TM; Itani KM; Hawn MT
    Am Surg; 2013 May; 79(5):514-23. PubMed ID: 23635588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery: a systematic review of clinical practice guidelines.
    Darvish-Kazem S; Gandhi M; Marcucci M; Douketis JD
    Chest; 2013 Dec; 144(6):1848-1856. PubMed ID: 23928727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-life management of dual antiplatelet therapy interruption: the REGINA survey.
    Collet JP; Aout M; Alantar A; Coriat P; Napoléon B; Thomas D; Trosini-Desert V; Tucas G; Vicaut E; Montalescot G
    Arch Cardiovasc Dis; 2009 Oct; 102(10):697-710. PubMed ID: 19913771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bridging with GP IIb/IIIa inhibitors after abdominal surgery in a patient presenting with late stent thrombosis of a drug-eluting stent and who cannot receive oral antiplatelet treatment.
    Ben-Dor I; Waksman R
    J Invasive Cardiol; 2009 Apr; 21(4):E73-6. PubMed ID: 19342766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents.
    Eisenberg MJ; Richard PR; Libersan D; Filion KB
    Circulation; 2009 Mar; 119(12):1634-42. PubMed ID: 19289638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-eluting stents: patient understanding of the risks of premature cessation of antiplatelet drugs.
    Trentman TL; Rosenfeld DM; Danielson DR; Hagstrom SG
    J Cardiothorac Vasc Anesth; 2008 Dec; 22(6):806-10. PubMed ID: 18834797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Rossini R; Musumeci G; Aprile A; Valsecchi O
    Expert Rev Pharmacoecon Outcomes Res; 2010 Feb; 10(1):49-61. PubMed ID: 20121564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding.
    May AE; Geisler T; Gawaz M
    Thromb Haemost; 2008 Mar; 99(3):487-93. PubMed ID: 18327396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perioperative antiplatelet therapy.
    Chassot PG; Marcucci C; Delabays A; Spahn DR
    Am Fam Physician; 2010 Dec; 82(12):1484-9. PubMed ID: 21166368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of late drug-eluting stent thrombosis with non-cardiac surgery.
    Chia KK; Park JJ; Postle J; Cottrill A; Ward MR
    Am J Cardiol; 2010 Jul; 106(1):1-3. PubMed ID: 20609638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peri-operative management of anticoagulation and antiplatelet therapy in gastrointestinal surgery.
    Degirmenci SE; Steib A
    J Visc Surg; 2014 Apr; 151(2):125-35. PubMed ID: 24631468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.